FDA Inspection 1143995 — AmerisourceBergen Drug Corporation
The FDA completed an inspection of AmerisourceBergen Drug Corporation on June 14, 2021 in Honolulu, HI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 14, 2021
- Fiscal Year
- 2021
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Honolulu, HI (United States)